EQ Resources

Showing 6124 articles
Business

Olin Stock Surges 11% on Strong Sales Momentum, Despite Annual Loss

Shares of chemical manufacturer Olin Corporation (NYSE: OLN) jumped nearly 11% on Wednesday, extending a three-day rally as the market reacted to its 2025 sales growth. The gain comes despite the company reporting a swing to an annual net loss, highlighting investor focus on revenue resilience amid a challenging chemical sector environment.

Business

Novo Nordisk's Stock Slump: A Buying Opportunity or a Sign of Deeper Trouble?

Shares of the Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) have retreated sharply, down 14% in a month and 44% over the past year. With the stock closing at $47.19, a significant gap has emerged between its market price and some fair value estimates near $95, prompting investors to reassess the company's prospects amid evolving competition in its key GLP-1 drug market.